VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $390,000 | -87.5% | 14,833 | -51.7% | 0.00% | -89.5% |
| Q4 2015 | $3,122,000 | +92.5% | 30,718 | +237.8% | 0.02% | +72.7% |
| Q3 2015 | $1,622,000 | -38.8% | 9,093 | -23.8% | 0.01% | -35.3% |
| Q2 2015 | $2,652,000 | +46.7% | 11,938 | +31.1% | 0.02% | +41.7% |
| Q1 2015 | $1,808,000 | +36.8% | 9,107 | -1.5% | 0.01% | +33.3% |
| Q4 2014 | $1,322,000 | +7.1% | 9,243 | -1.8% | 0.01% | 0.0% |
| Q3 2014 | $1,234,000 | +4.0% | 9,415 | -0.0% | 0.01% | +12.5% |
| Q2 2014 | $1,186,000 | – | 9,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |